|
Delayed
Japan Exchange
03:57:39 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 242.00 JPY | -1.63% |
|
-3.59% | -28.82% |
Company Valuation: Tsubota Laboratory Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Market Cap 1 | 20,979 | 9,054 | 10,102 | 7,584 |
| Change | - | -56.84% | 11.57% | -24.93% |
| Enterprise Value (EV) 1 | 18,956 | 7,287 | 8,654 | 6,683 |
| Change | - | -61.56% | 18.75% | -22.78% |
| P/E | 236x | -14.1x | 49.7x | -9.95x |
| PBR | 10.7x | 6.62x | 6.36x | 8.79x |
| PEG | -4.9x | 0x | -0x | 0x |
| Capitalization / Revenue | 22x | 13.5x | 7.44x | 37.9x |
| EV / Revenue | 19.9x | 10.8x | 6.38x | 33.4x |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | 114x | -11.2x | 36.7x | -8.49x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | 3.52 | -25.14 | 7.92 | -29.55 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 954 | 673 | 1,357 | 200 |
| EBITDA | 206 | -615 | 264 | -767 |
| EBIT 1 | 167 | -650 | 236 | -787 |
| Net income 1 | 90 | -641 | 205 | -761 |
| Net Debt 1 | -2,023 | -1,767 | -1,448 | -901 |
| Reference price 2 | 829.00 | 354.00 | 394.00 | 294.00 |
| Nbr of stocks (in thousands) | 25,307 | 25,578 | 25,639 | 25,794 |
| Announcement Date | 29/6/23 | 27/6/24 | 26/6/25 | 19/6/26 |
1JPY in Million2JPY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 40.2M | ||
| 16.92x | 6.39x | 12.26x | 1.77% | 64.38B | ||
| 30.57x | 8.11x | 26.59x | 0.05% | 56.16B | ||
| 36.68x | 6.52x | 19.45x | 0.88% | 54.16B | ||
| 35.39x | 3.41x | 14.74x | -.--% | 45.33B | ||
| 49.25x | 5.68x | 31.09x | -.--% | 42.25B | ||
| -19.59x | 189.6x | -20.86x | -.--% | 40.78B | ||
| 47.12x | 8.37x | 28.08x | -.--% | 33.8B | ||
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | ||
| 27.96x | 5.9x | 15.29x | -.--% | 23.57B | ||
| Average | 28.44x | 26.89x | 16.40x | 0.34% | 39.27B | |
| Weighted average by Cap. | 27.89x | 25.54x | 16.43x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4890 Stock
- Valuation Tsubota Laboratory Incorporated
Select your edition
All financial news and data tailored to specific country editions
















